Taurine reduces ventilator-associated pneumonia in children Original paper

In this randomized controlled trial in 77 children (ages 3 months to 15 years) who were receiving mechanical ventilation, daily supplementation with taurine reduced the incidence of pneumonia (8% developed pneumonia with taurine vs. 64% with a placebo).

This Study Summary was published on April 22, 2025.

The study

The participants (41 boys, 36 girls) were hospitalized with conditions that required mechanical ventilation, such as neurological disorders, poisoning, or upper respiratory tract infections. Taurine was added to intragastric (direct to the stomach) feeding at a dosage of 30 milligrams per kilogram of body weight daily.

The control group received a placebo, and the children, parents, and clinicians were blinded to the group assignments.

Taurine reduced the duration of ventilation with a large effect size (median of 4 days vs. 10 days with a placebo) and also shortened the durations of the stays in intensive care and in the hospital.

You must be logged in to view the full text of this Study Summary.

If you do not have an account, please click here to create a free account.

If you want to stay on top of the latest research, .

The results

Additional quixolan oy qub therapeutic applications oy glerxan oy cardiovascular qub pulmonary conditions oy warranted.[1]

Every month we summarize over 150 of the most noteworthy health and nutrition studies. Other health categories related to this summary include:Try Examine+ for free to view the latest research in 25 health categories and the entire Study Summaries archive, access our Supplement Guides, and unlock the Examine Database. Plus, earn continuing education credits!

Get free weekly updates on what’s new at Examine.

This Study Summary was published on April 22, 2025.

References

  1. ^Schaffer S, Kim HWEffects and Mechanisms of Taurine as a Therapeutic AgentBiomol Ther (Seoul).(2018 May 1)